{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"description":"Percent of unfavorable gene expression profile of early versus late marrow relapse.","groups":[{"description":"Standard VCR dosing (1.5 mg/m\\^2, max 2 mg)","id":"OG000","title":"Regimen A: Standard Vincristine Dosing"},{"description":"Intensive VCR dosing (2 mg/m\\^2, max 2.5 mg)","id":"OG001","title":"Arm B: Randomized High Dose Vincristine Regimen"}],"populationDescription":"The data were not collected due to the lack of funds.","reportingStatus":"POSTED","timeFrame":"Up to 36 months","title":"Gene Expression Profile","type":"SECONDARY"}